Evidence map›Paper›PMID 42484529›Full record

ArticleNephrology nursing journal : journal of the American Nephrology Nurses' Association

Development and Psychometric Evaluation of the End-Stage Renal Disease Adherence Questionnaire-Short Form: English, Spanish, and Korean Versions.

Youngmee Kim, Won-Kyung Cho, Jooyoun Song, Lorraine S Evangelista, Joel D Kopple

Abstract read
In one paragraph

Article in Nephrology nursing journal : journal of the American Nephrology Nurses' Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Youngmee KimProfessor, Red Cross College of Nursing, Chung-Ang University, Seoul, Korea.
Won-Kyung ChoClinical Professor, International Healthcare Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jooyoun SongRegistered Nurse, Yonsei-Saebom Internal Medicine Clinic: Hemodialysis Center, Gyeyang-gu, Incheon, Republic of Korea.
Lorraine S EvangelistaProfessor Emeritus, Sue & Bill Gross School of Nursing, UC Irvine, Irvine, CA.
Joel D KoppleProfessor Emeritus of Medicine and Public Health at the David Geffen School of Medicine and the Fielding School of Public Health, UCLA; and an Investigator, The Lundquist Institute for Biomedical Innovation at Harbor‑UCLA Medical Center, Torrance, CA.

Funding

Examining the Effects of High Protein Diet on Outcomes in Heart Failure PatientsR01HL093466 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EVANGELISTA, LORRAINE S · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL093466
6 · The paper itself

Abstract

The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ) evaluates adherence behaviors of patients on maintenance hemodialysis (e.g., hemodialysis attendance, medication use, fluid restrictions, and diet restrictions). The ESRD-AQ, with 46 items, is considered lengthy by some clinicians with time constraints. Therefore, this study was conducted to develop and psychometrically evaluate a 9-item short form of the ESRD-AQ (ESRD-AQ-SF) for faster and more efficient administration. Content validity, construct validity, and test-retest reliability were assessed. Results demonstrated that the ESRD-AQ-SF is a valid and reliable tool for evaluating treatment adherence in patients undergoing maintenance hemodialysis.

Indexed as

Kidney Failure, ChronicPatient CompliancePsychometricsRenal DialysisAdultAgedFemaleHumansMaleMiddle AgedReproducibility of ResultsRepublic of KoreaSurveys and QuestionnairesadherenceESRD-AQESRD-AQ-SFhemodialysisquestionnairereliabilityshort formvalidity

Identifiers

PMID42484529
PMCPMC13598919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.